This trial studies how well evidence-based psychotherapy works in reducing stress from cancer or cancer treatment for patients or their caregivers. Psycho-oncology is a field focused on improving the emotional and physical wellbeing of people during cancer treatment, after cancer treatment, in long-term cancer treatment, and at the end of life. This trial trains therapists in specific treatments that have been effective in people with cancer, including Cognitive Behavioral Therapy (CBT), Acceptance Commitment Therapy (ACT), Mindfulness-Based Cognitive Therapy (MBCT), Mindfulness-Based Stress Reduction (MBSR), Meaning-Centered Psychotherapy (MCP), Cognitive Behavioral Therapy for Insomnia (CBT-I), and CBT for other cancer-related physical symptoms like pain and fatigue. The goal of this trial is to provide more experience to clinical psychology fellows and psychiatry residents in the delivery of therapy focused on adjustment to cancer and its treatment for patients and caregivers.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT05674357.
Locations matching your search criteria
United States
Massachusetts
Boston
Massachusetts General Hospital Cancer CenterStatus: Active
Contact: Jamie Jacobs
Phone: 617-643-1777
Concord
Emerson Hospital/MGH Cancer CenterStatus: Active
Contact: Jamie Jacobs
Phone: 617-643-1777
Danvers
Mass General/North Shore Cancer CenterStatus: Active
Contact: Jamie Jacobs
Phone: 617-643-1777
Newton
Newton-Wellesley HospitalStatus: Active
Contact: Jamie Jacobs
Phone: 617-643-1777
PRIMARY OBJECTIVES:
I. To train psychotherapists at the Massachusetts (Mass) General’s Center for Psychiatric Oncology & Behavioral Sciences to administer evidence-based therapies for patients and caregivers with elevated levels of distress related to their illness, treatment (e.g., cancer treatment) and/or caregiving experience.
II. To examine changes from pre- to post-treatment in patient and caregiver psychosocial outcomes (e.g., coping self-efficacy, quality of life (QOL), depressive symptoms, anxiety symptoms, pain, fatigue, sleep disturbance).
EXPLORATORY OBJECTIVES:
I. To explore baseline sociodemographic characteristics, clinical and treatment factors, and psychosocial factors associated with changes in patient and caregiver psychosocial outcomes.
II. To explore changes in therapist self-efficacy every three months throughout the study using the Counselor Activity Self-Efficacy Scales and a semi-structured exit interview with therapists one year following their enrollment.
OUTLINE: Participants are assigned to 1 of 2 arms.
ARM I: Patients or caregivers undergo 6-16 sessions of evidence-based psychotherapy on study. Patients may also undergo 4 additional booster sessions as clinically indicated.
ARM II: Therapists undergo training for evidence-based psychotherapy on study. Therapists then deliver the evidence-based psychotherapy to patients per Arm I on study.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationDana-Farber Harvard Cancer Center
Principal InvestigatorJamie Jacobs